INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks|New Special Series Myeloid Cells in Immuno-Oncology| JITC Meet-the-Editor Seession at JACI (Japan)| Popular Articles Letter from the Editor Hello JITC Readers, This month I would...
The Society for Immunotherapy of Cancer (SITC) has submitted comments to the Office of Management and Budget (OMB) regarding proposed changes to the regulations governing Federal Financial Assistance . View the comments in their entirety at this LINK . For decades, independent...
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, SITC will periodically distribute information about newly approved therapies for cancer patients. This helps the FDA inform oncologists and professionals in oncology-related fields of recent approvals in...
A Message from the President As Cancer Immunotherapy Awareness Month comes to a close, I’m reflecting on the remarkable progress and momentum in the field of cancer immuno-oncology. Throughout June, our community celebrated the scientific advances, collaboration and innovation that are...
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks|SITC 40 th Anniversary Special Series| Popular Articles Letter from the Editor Hello JITC Readers, June is Cancer Immunotherapy Month—a time to celebrate the remarkable progress...
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, June 2, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific highlights) Fitness-enhanced CEA-targeting CAR T cells for...
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, June 1, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific highlights) Live biotherapeutic CBM588 improves the...
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 31, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific highlights) Final safety, efficacy and biomarker...